tweetindex
ID

STAT ✓

@statnews · joined 24 Jul 2015

Reporting from the frontiers of health & medicine. Sign up for any of our newsletters here: https://t.co/CBx3GZBv31

165 179Followers
4 741Following
88 842Posts total
18.5KViews on collected posts

Postingan terbaru

Why are drug overdose deaths declining? A new report points to policy measures like naloxone and harm reduction. https://t.co/cRC76zOFby 850 views · 1 likes · 0 reposts · 0 replies Open on X →
@statnews imagine denying children healthcare because you have to spend a little extra time answering hard questions from their parents 8 views · 0 likes · 0 reposts · 0 replies Open on X →
Abivax has still not been acquired. What’s going on? https://t.co/M9ZEuzSaQ8 977 views · 1 likes · 0 reposts · 0 replies Open on X →
Abivax has still not been acquired. What’s going on? https://t.co/BP2NOwohxR 1.1K views · 1 likes · 0 reposts · 0 replies Open on X →
Led by Nobel laureate David Baker and genome scientist Jay Shendure, a new $95 million effort is launching in Seattle to use AI to design biology that doesn't exist in nature: https://t.co/8v5L15vDh0 2.4K views · 3 likes · 3 reposts · 0 replies Open on X →
The pediatricians who take in vaccine-skeptical parents others won’t https://t.co/4gewvlpuoT 2.1K views · 2 likes · 0 reposts · 1 replies Open on X →
@statnews I made a different poster for you guys because same shit different poster.. https://t.co/e4Pw5uMara
66 views · 0 likes · 0 reposts · 0 replies Open on X →
@statnews $nwbo unbelievable phase lll results in 2022. Waiting for @MHRAgovuk approval anyday. Works on ALL solid tumor cancers. No side effects. 2.3K views · 43 likes · 5 reposts · 3 replies Open on X →
A personalized mRNA cancer vaccine succeeded in a late-stage melanoma study, results that could herald a new, powerful approach in oncology. https://t.co/rFgy8zqSIq 8.7K views · 34 likes · 8 reposts · 2 replies Open on X →

Dibandingkan akun berukuran sama

9 postingan dari 90 hari terakhir, dibandingkan dengan rentang 100K–1M pengikut. di bawah akun sekelasnya baik pada jangkauan maupun interaksi.

Median tayangan1 063akun ini5 983median untuk 100K–1M
Jangkauan, %0.64%akun ini1.49%median untuk 100K–1M
Interaksi, %0.12%akun ini0.93%median untuk 100K–1M
MetrikAkun iniMedian untuk 100K–1MRasio
Median tayangan per postingan1 0635 9830.18×
Jangkauan (tayangan ÷ pengikut)0.64%1.49%0.43×
Tingkat interaksi0.12%0.93%0.13×

Akun lain pada rentang ini →   Bandingkan dengan akun lain →   Bagaimana tolok ukur ini disusun →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

8.7K19 Aug
2.3K
66
2.1K3 Sep
2.4K
1.1K
977
8
850

Last 9 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.56%19 Aug
2.33%
0.00%
0.14%3 Sep
0.25%
0.09%
0.10%
0.00%
0.12%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 0.93%.

What the audience does

Likes69.1%85 in total
Reposts13.0%16 in total
Replies4.9%6 in total
Quotes5.7%7 in total
Bookmarks7.3%9 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Akun serupa